
Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Март 3, 2025
Background NUP62, a key component of the nuclear pore complex, is closely associated with cellular functions and cancer progression. However, its expression patterns, prognostic value, relationship tumour immunity drug sensitivity across multiple cancers have not been systematically studied. This study used multi-omics analyses combined experimental validation in gastric to investigate expression, functional characteristics, clinical relevance NUP62 cancer. Methods Data from TCGA, GTEx, CPTAC databases were analyse mutation associations NUP62. Tools such as SangerBox, TIMER 2.0, GSEA employed evaluate between immune microenvironment, well involvement signalling pathways. Immunohistochemistry RT-PCR validate tissues. PRISM CTRP utilised assess correlation sensitivity. Results was significantly upregulated poor prognosis clear cell renal carcinoma (KIRC), lower-grade glioma (LGG), adrenocortical (ACC), while playing protective role others, bladder (BLCA) stomach (STAD). Functional showed that involved cycle regulation, DNA damage repair, immunity. High correlated increased infiltration cells, macrophages T higher response rate immunotherapy. Drug analysis identified marker various chemotherapeutic agents. Validation experiments demonstrated mRNA protein levels tissues than adjacent normal Conclusions plays critical shows potential biomarker for diagnosis, prognosis, therapeutic prediction. Its pathways highlights target immunotherapy precision medicine.
Язык: Английский